Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
s.l; s.n; 1995. 7 p. ilus, tab.
Não convencional em Inglês | Sec. Est. Saúde SP, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1242739

RESUMO

Thirteen dogs naturally infected with Leishmania infantum showing viscerocutaneous signs of disease were treated with different dosages of liposomal amphotericin B (AmBisome) 3-3.3 kg showed rapid clinical improvement, with regression of lymphadenomegaly and splenomegaly, and cure of skin lesions. The clinical response was similar to that obtained with 14-21 doses of conventional antileishmanial drugs. However, follow-up lymph node aspirates remained positive for Leishmania in all dogs except one, which was treated with the total dose ofAmBisome 15 mg kg. The failure in parasitological cure may be due to inadequate drug targeting to parasitized cells, or to T-cell immune depression characteristic of patent cases of canine leishmaniasis, or to both


Assuntos
Humanos , Anfotericina B/biossíntese , Anfotericina B/química , Anfotericina B/toxicidade , Leishmania infantum/fisiologia , Leishmania infantum/genética , Leishmania infantum/patogenicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA